CASI Stock Earnings: CASI Pharmaceuticals Beats EPS, Misses Revenue for Q2 2024
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Aug 16 2024
0mins
Source: Business Insider
CASI Pharmaceuticals Q2 2024 Results: CASI Pharmaceuticals reported a second-quarter earnings per share of -52 cents, surpassing the analyst estimate of -63 cents, but their revenue of $3.98 million fell short of the expected $4.43 million by 10.18%.
InvestorPlace Earnings Automation: InvestorPlace Earnings utilizes automated data from TradeSmith to provide timely coverage of quarterly earnings reports, highlighting key metrics like EPS and revenue against analyst estimates without human intervention.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
